Genelux Corporation (GNLX)
(Real Time Quote from BATS)
$2.63 USD
+0.01 (0.38%)
Updated May 28, 2024 11:15 AM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GNLX 2.63 +0.01(0.38%)
Will GNLX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for GNLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GNLX
Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround
GNLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX)
All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy
IPO Round Up of First Half of 2023
Other News for GNLX
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
LIDR, HOOK and BCAB among mid-day movers
12 Health Care Stocks Moving In Friday's Intraday Session
Nasdaq Gains 1%; Intuit Shares Plunge